Enhancing Decision Making within the Life Sciences through the use of Semantic Technologies

author: Susie Stephens, Johnson & Johnson
published: Jan. 18, 2010,   recorded: December 2009,   views: 3693

Related Open Educational Resources

Related content

Report a problem or upload files

If you have found a problem with this lecture or would like to send us extra material, articles, exercises, etc., please use our ticket system to describe your request and upload the data.
Enter your e-mail into the 'Cc' field, and we will keep you updated with your request's status.
Lecture popularity: You need to login to cast your vote.


Bringing new drugs to market is hard. It requires understanding how novel compounds will influence disease across heterogeneous populations. It also requires the demonstration of comparative effectiveness of therapies, the minimization of safety related risk, and meeting global regulatory requirements. In order to spur innovation, companies are exploring the adoption of new business models, which include bringing fresh ideas into organizations through collaboration, and enhancing product development through tightening the connection between drug discovery and the clinical environment. This presentation will describe how Semantic Web technologies can benefit companies in light of new business models, and will provide examples as to how Semantic Web technology is currently being used within Johnson and Johnson.

Link this page

Would you like to put a link to this lecture on your homepage?
Go ahead! Copy the HTML snippet !

Write your own review or comment:

make sure you have javascript enabled or clear this field: